ACADIA Pharmaceuticals Inc. (ACAD)

Last Closing Price: 17.59 (2026-11-19)

Weighted-Average Shares Outstanding (Diluted) (Quarterly)

Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.

ACADIA Pharmaceuticals Inc. (ACAD) had Weighted-Average Shares Outstanding (Diluted) of 175.47M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$342.29M
$53.52M
$35.09M
$307.20M
$270.57M
$71.72M
$8.72M
$80.44M
$80.44M
$53.52M
$53.52M
$53.52M
$53.52M
$71.72M
$75.23M
172.54M
Weighted-Average Shares Outstanding (Diluted)
175.47M
$0.31
$0.31
Balance Sheet Financials
$1.27B
$18.40M
$525.73M
$1.79B
$332.22M
--
$74.44M
$406.66M
$1.39B
$1.25B
$1.39B
172.79M
Cash Flow Statement Financials
$146.26M
$-28.40M
$26.60M
$185.54M
$330.21M
$144.67M
$49.09M
--
--
Fundamental Metrics & Ratios
3.82
--
--
--
--
89.75%
20.95%
20.95%
--
23.50%
15.64%
$134.72M
--
--
--
0.19
0.87
1.92
46.89
3.86%
4.28%
2.98%
3.86%
$8.03
$0.77
$0.83